scispace - formally typeset
D

Dana Pe'er

Researcher at Memorial Sloan Kettering Cancer Center

Publications -  177
Citations -  35583

Dana Pe'er is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Biology & Cancer. The author has an hindex of 58, co-authored 138 publications receiving 27233 citations. Previous affiliations of Dana Pe'er include Hebrew University of Jerusalem & Massachusetts Institute of Technology.

Papers
More filters
Journal ArticleDOI

Using Bayesian networks to analyze expression data

TL;DR: A new framework for discovering interactions between genes based on multiple expression measurements is proposed and a method for recovering gene interactions from microarray data is described using tools for learning Bayesian networks.
Journal ArticleDOI

Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum

TL;DR: Single-cell “mass cytometry” analyses provide system-wide views of immune signaling in healthy human hematopoiesis, against which drug action and disease can be compared for mechanistic studies and pharmacologic intervention.
Journal ArticleDOI

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.

Carly G. K. Ziegler, +135 more
- 28 May 2020 - 
TL;DR: The data suggest that SARS-CoV-2 could exploit species-specific interferon-driven upregulation of ACE2, a tissue-protective mediator during lung injury, to enhance infection.
Journal ArticleDOI

Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data

TL;DR: The procedure identifies modules of coregulated genes, their regulators and the conditions under which regulation occurs, generating testable hypotheses in the form 'regulator X regulates module Y under conditions W'.
Journal ArticleDOI

Causal Protein-Signaling Networks Derived from Multiparameter Single-Cell Data

TL;DR: Reconstruction of network models from physiologically relevant primary single cells might be applied to understanding native-state tissue signaling biology, complex drug actions, and dysfunctional signaling in diseased cells.